Comment on Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

Basit Öğe Kaydı
dc.contributor.authorCure, Erkan
dc.contributor.authorCure, Medine Cumhur
dc.contributor.authorKucuk, Adem
dc.date.accessioned2024-02-23T13:59:34Z
dc.date.available2024-02-23T13:59:34Z
dc.date.issued2020
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.doi10.1007/s11481-020-09938-3
dc.identifier.endpage346en_US
dc.identifier.issn1557-1890
dc.identifier.issn1557-1904
dc.identifier.issue3en_US
dc.identifier.pmid32588188en_US
dc.identifier.scopus2-s2.0-85086864838en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage345en_US
dc.identifier.urihttps://doi.org/10.1007/s11481-020-09938-3
dc.identifier.urihttps://hdl.handle.net/20.500.12452/11244
dc.identifier.volume15en_US
dc.identifier.wosWOS:000543270300001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal Of Neuroimmune Pharmacologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleComment on Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?en_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu